Robert Charles Breedlove, Principal Accounting Officer at Phathom Pharmaceuticals, Inc. (PHAT), sold 524 shares at $13.51 ($7K) on 2025-11-03, disclosed to the SEC on 2025-11-05.
Open-market sale of $7k PHAT by Principal Accounting Officer. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Nothing distinguishes this filing.
| Filing → |